# Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

> **NCT00146224** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 420 (estimated)

## Conditions studied

- Nephrology

## Interventions

- **DRUG:** Epoetin alfa RB
- **DRUG:** Epoetin alfa DT

## Key facts

- **NCT ID:** NCT00146224
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2010-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146224, "Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00146224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*